Skip to content
Explore premium insights on luxury living, exclusive events…

Users Stopping Anti-Obesity Medications Gain Back Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

Image of pharmaceutical injection and scale
Weight management involves long-term strategies.

A recent study suggests that individuals who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle plans.

Findings released in a major health publication demonstrates that while overweight people often shed about a fifth of their total mass while on the medication, the weight is regained at an average rate of nearly a kilo each month after stopping.

"People using these treatments must be informed of the risk of quick rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.

This pace of regain means a reversion to starting weight within about one and a half years.

Comparing Therapies

The study, which examined dozens of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.

Researchers point out that individuals who shed pounds through diet and exercise usually experience a less rapid weight regain—approximately 100 grams monthly—after stopping.

The Reason for the Fast Regain

Doctors suggest the way of the injections explains the accelerated weight return.

These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making excessive eating a significant risk."

A Lifelong Condition?

The NHS recommend the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.

Professionals contend that, given the likelihood of weight regain, the treatment is often ongoing.

This perspective is echoed by drug manufacturers, who state that the findings "highlight the long-term nature of obesity," akin to managing conditions like hypertension.

User Experiences

Users who have stopped the medication report a sudden return of appetite.

"I experienced something that goes on and you're instantly starving," described one woman.

This challenge is compounded if patients have not established lasting dietary or behavioural changes during therapy.

Widespread Use

Figures suggest that millions of people in the UK have used these injections in the last 12 months, with demand remaining high.

  • Use is higher among females than men.
  • The middle-aged demographic shows the highest usage rates.
  • Many access the drugs through private prescriptions rather than public health services.

Finally, clinicians emphasize that while these medications are potent agents for weight loss, they are not a permanent fix and maintained weight loss hinges on ongoing lifestyle changes.

About the author

Jared Lopez

Aria Sterling is a luxury lifestyle curator with over a decade of experience in high-end event planning and exclusive content creation.

Crystal Royal Network

Type to search articles.